Search
for
Sort by
Research 61–90 of 1000+
- No elevated risk for osteoporosis or osteopenia among women with androgenetic or frontal fribrosing alopecia treated with 5-alpha reductase inhibitors: A retrospective TriNetX cohort study
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor
- Natural Product-Inspired Bis(trifluoromethyl) Phenyl Hydroxycinnamate Derivatives as Promising Nonsteroidal Inhibitors of Human Steroid 5α-Reductase Type-1: Synthesis, <i>In Vitro</i>, and <i>In Silico</i> Studies
- Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease
- Dihydrotestosterone-Inducible IL-6 Inhibits Elongation of Human Hair Shafts by Suppressing Matrix Cell Proliferation and Promotes Regression of Hair Follicles in Mice
- Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models
- Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics
- 0248 Risk of infections in patients with hidradenitis suppurativa treated with TNF-α inhibitors vs. IL-17 inhibitors: A large-scale cohort study
- Association of breast cancer in men with exposure to 5-α reductase inhibitors: A RADAR report.
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- Wider clinical applications of fumaric acid esters: A useful option in psoriasis patients with multiple sclerosis
- Treatment of actinic cheilitis with ingenol mebutate gel: Experience in four patients
- Psoriasis and Alopecia: Unveiling the Links
- Current and future pharmacotherapy for alopecia areata
- Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis
- Comprehensive Evaluation of <i>Tectona grandis</i> L.f.: Integrated <i>In Vitro</i> and <i>In Silico</i> Analysis of Steroid 5α-Reductase Inhibition and Anti-Inflammatory Properties
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- A novel therapeutic paradigm for patients with extensive alopecia areata
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- Alopecia Areata After Initiation of Secukinumab Therapy for Plaque Psoriasis
- Generalized hypertrichosis associated with the use of interleukin 17 blockers in 2 patients with psoriasis
- Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Hair Growth Promoting Effects of 15-Hydroxyprostaglandin Dehydrogenase Inhibitor in Human Follicle Dermal Papilla Cells
- LB1007 Systemic treatment with a KLK5 inhibitor shows efficacy in a murine model of Netherton syndrome
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- 5α-Reduced glucocorticoids: a story of natural selection